U.S. Pharmaceutical Sales - Q1 2012
The following is a list of the top 100 prescribed medicines by US National Sales in Q1 2012. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q1 2012 by units sold
Rank |
Drug |
Units (000) |
|
|
1 |
budesonide Generic |
13,058 |
-2.53% |
Stats |
2 |
acetaminophen/hydrocodone Generic |
9,380 |
-0.89% |
Stats |
3 ( 2) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
7,919 |
13.65% |
Stats |
4 ( 1) |
OneTouch
|
7,299 |
3.61% |
Stats |
5 ( 1) |
Singulair Merck |
6,886 |
-0.03% |
Stats |
6 ( 2) |
Nexium AstraZeneca |
6,572 |
-6.18% |
Stats |
7 |
Cymbalta
|
6,101 |
0.66% |
Stats |
8 ( 1) |
Lantus Sanofi |
5,883 |
-0.08% |
Stats |
9 ( 1) |
Advair Diskus GlaxoSmithKline |
5,804 |
-1.43% |
Stats |
10 ( ) |
Ventolin HFA GlaxoSmithKline |
5,704 |
n/a |
Stats |
11 ( 1) |
Plavix
|
5,251 |
0.23% |
Stats |
12 ( 2) |
AndroGel AbbVie Inc. |
4,078 |
4.43% |
Stats |
13 |
Crestor AstraZeneca |
3,926 |
-3.70% |
Stats |
14 ( 23) |
atorvastatin Generic |
3,765 |
116.38% |
Stats |
15 ( 3) |
fentanyl Generic |
3,738 |
-11.90% |
Stats |
16 ( 1) |
Lantus Solostar Sanofi |
3,737 |
7.32% |
Stats |
17 ( 1) |
enoxaparin Generic |
3,488 |
0.55% |
Stats |
18 ( 1) |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
3,399 |
5.62% |
Stats |
19 ( 1) |
Novolog Novo Nordisk |
2,980 |
3.72% |
Stats |
20 ( 1) |
Nasonex Merck |
2,818 |
5.31% |
Stats |
21 ( 1) |
Levemir Novo Nordisk |
2,752 |
8.69% |
Stats |
22 ( 2) |
Humalog Eli Lilly and Company |
2,570 |
-3.85% |
Stats |
23 ( 2) |
NovoLog FlexPen Novo Nordisk |
2,489 |
13.81% |
Stats |
24 ( 3) |
Abilify Otsuka Pharmaceutical Co., Ltd |
2,488 |
-3.15% |
Stats |
25 ( 2) |
metoprolol Generic |
2,366 |
-6.30% |
Stats |
26 ( 2) |
Januvia Merck |
2,227 |
4.41% |
Stats |
27 |
Diovan Novartis Pharmaceuticals Corporation |
2,099 |
-1.64% |
Stats |
28 ( 2) |
Namenda Allergan plc |
2,054 |
1.83% |
Stats |
29 |
Lyrica
|
1,991 |
-2.02% |
Stats |
30 ( 1) |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
1,988 |
-1.29% |
Stats |
31 ( 1) |
Zetia Merck |
1,952 |
0.41% |
Stats |
32 ( 21) |
Lipitor
|
1,939 |
-60.83% |
Stats |
33 ( 9) |
Actos Takeda Pharmaceutical Company Limited |
1,912 |
-12.97% |
Stats |
34 ( 1) |
Flovent HFA GlaxoSmithKline |
1,890 |
-1.66% |
Stats |
35 ( 1) |
Suboxone
|
1,870 |
2.58% |
Stats |
36 ( 1) |
Symbicort AstraZeneca |
1,850 |
5.59% |
Stats |
37 ( 1) |
Seroquel AstraZeneca |
1,654 |
-5.27% |
Stats |
38 |
Lidoderm Endo Pharmaceuticals Inc. |
1,568 |
-5.88% |
Stats |
39 ( 3) |
Remicade Janssen Pharmaceuticals, Inc. |
1,556 |
10.04% |
Stats |
40 ( 1) |
Lovaza GlaxoSmithKline |
1,537 |
-4.53% |
Stats |
41 ( 1) |
Benicar Daiichi Sankyo |
1,475 |
-1.60% |
Stats |
42 ( 16) |
Lexapro Allergan plc |
1,445 |
-32.38% |
Stats |
43 ( ) |
Dexilant Takeda Pharmaceutical Company Limited |
1,341 |
n/a |
Stats |
44 ( 3) |
Vytorin Merck |
1,312 |
-7.28% |
Stats |
45 ( 2) |
Restasis Allergan plc |
1,291 |
-3.73% |
Stats |
46 ( 2) |
Diovan HCT Novartis Pharmaceuticals Corporation |
1,251 |
-3.77% |
Stats |
47 ( 2) |
OxyContin Purdue Pharma LP |
1,249 |
-2.35% |
Stats |
48 |
olanzapine Generic |
1,172 |
13.35% |
Stats |
49 ( 3) |
Lovenox Sanofi |
1,089 |
-0.73% |
Stats |
50 ( 3) |
Niaspan AbbVie Inc. |
1,025 |
-4.74% |
Stats |
51 |
Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc. |
1,011 |
6.53% |
Stats |
52 ( 2) |
VESIcare Astellas Pharma US, Inc. |
980 |
0.93% |
Stats |
53 ( 4) |
Celebrex
|
977 |
-5.42% |
Stats |
54 ( 1) |
Janumet Merck |
959 |
5.97% |
Stats |
55 ( 3) |
TriCor AbbVie Inc. |
861 |
-8.11% |
Stats |
56 ( 1) |
Enbrel Amgen Inc. |
823 |
-4.63% |
Stats |
57 ( 1) |
Aciphex Eisai Inc. |
792 |
-4.81% |
Stats |
58 ( 1) |
Vyvanse Takeda Pharmaceutical Company Limited |
791 |
4.08% |
Stats |
59 ( ) |
escitalopram Generic |
773 |
n/a |
Stats |
60 ( 1) |
methylphenidate Generic |
771 |
12.23% |
Stats |
61 ( 2) |
Cialis Eli Lilly and Company |
659 |
8.75% |
Stats |
62 ( 1) |
amphetamine/dextroamphetamine Generic |
654 |
1.71% |
Stats |
63 ( 3) |
Truvada Gilead Sciences, Inc. |
577 |
2.85% |
Stats |
64 ( 4) |
Epogen Amgen Inc. |
555 |
-17.04% |
Stats |
65 ( 2) |
Rituxan Genentech, Inc. |
547 |
-0.91% |
Stats |
66 ( 1) |
Humira AbbVie Inc. |
546 |
-2.85% |
Stats |
67 ( 3) |
Rebif EMD Serono, Inc. |
540 |
-9.09% |
Stats |
68 ( 10) |
Geodon
|
520 |
-25.71% |
Stats |
69 |
Atripla Gilead Sciences, Inc. |
489 |
1.45% |
Stats |
70 |
Avastin Genentech, Inc. |
460 |
-2.13% |
Stats |
71 ( 1) |
Seroquel XR AstraZeneca |
449 |
-2.18% |
Stats |
72 ( 4) |
Provigil
|
447 |
-12.01% |
Stats |
73 ( 2) |
Viagra
|
446 |
-3.88% |
Stats |
74 ( 1) |
Adderall XR Takeda Pharmaceutical Company Limited |
424 |
6.27% |
Stats |
75 ( 1) |
Lunesta Sunovion Pharmaceuticals Inc. |
348 |
-5.18% |
Stats |
76 ( 1) |
Neulasta Amgen Inc. |
331 |
1.53% |
Stats |
77 ( 15) |
Zyprexa
|
325 |
-47.07% |
Stats |
78 ( ) |
Orencia Bristol-Myers Squibb Company |
314 |
n/a |
Stats |
79 ( 2) |
Procrit Janssen Pharmaceuticals, Inc. |
295 |
-4.22% |
Stats |
80 ( 4) |
Aranesp Amgen Inc. |
293 |
-7.86% |
Stats |
81 ( 2) |
Solodyn Medicis Pharmaceutical Corporation |
293 |
2.45% |
Stats |
82 ( 4) |
Reyataz Bristol-Myers Squibb Company |
284 |
-1.73% |
Stats |
83 ( 2) |
Eloxatin Sanofi |
274 |
5.79% |
Stats |
84 ( 2) |
Erbitux Eli Lilly and Company |
266 |
3.91% |
Stats |
85 ( 2) |
Isentress Merck |
244 |
2.09% |
Stats |
86 ( 4) |
Synagis MedImmune, Inc. |
240 |
38.73% |
Stats |
87 ( 3) |
Lucentis Genentech, Inc. |
224 |
-5.88% |
Stats |
88 ( 3) |
Copaxone Teva Pharmaceuticals USA, Inc. |
212 |
-7.42% |
Stats |
89 ( 2) |
Prezista Janssen Pharmaceuticals, Inc. |
207 |
4.02% |
Stats |
90 ( 1) |
Alimta Eli Lilly and Company |
174 |
-0.57% |
Stats |
91 ( 3) |
Neupogen Amgen Inc. |
170 |
-2.86% |
Stats |
92 |
Herceptin Genentech, Inc. |
155 |
n/a |
Stats |
93 ( 2) |
Prevnar 13 Pfizer Inc. |
155 |
-5.49% |
Stats |
94 ( 1) |
Velcade Takeda Pharmaceutical Company Limited |
146 |
2.82% |
Stats |
95 ( 1) |
Zyvox Pfizer Inc. |
145 |
3.57% |
Stats |
96 ( 1) |
Avonex Biogen |
130 |
-3.70% |
Stats |
97 |
Pegasys Genentech, Inc. |
87 |
3.57% |
Stats |
98 ( 2) |
Gleevec Novartis Pharmaceuticals Corporation |
79 |
-8.14% |
Stats |
99 ( 1) |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
67 |
-10.67% |
Stats |
100 |
Incivek Vertex Pharmaceuticals Incorporated |
24 |
-17.24% |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.